A Multicenter Open-Label Study of RMC-6236 in Patients with Advanced Solid Tumors Harboring Specific Mutations in RAS

Go Back to All Clinical Trials

A Multicenter Open-Label Study of RMC-6236 in Patients with Advanced Solid Tumors Harboring Specific Mutations in RAS

Brief description of study

Clinical Study Identifier: s22-00364

ClinicalTrials.gov Identifier: NCT05379985

Principal Investigator: Salman Rafi Punekar.

Other Investigators: Nila Theresa De La Rosa, Joshua K Sabari, Samantha VanMaanen, Douglas K Marks, David R. Wise, Jessica Wang, Elaine Shum, Nina Beri, Kristen Spencer, Sally Lau, Scot Niglio, Keriann M Scavone, Kirby Rodriguez, Kathleen M Madden, Nancy Chan, Caitlin Elizabeth Ryan, Paul E. Oberstein, Eneil De La Pena, Janice Mehnert, Vamsidhar Velcheti.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies